A Study of Liposomal Doxorubicin+Docetaxel+Trastuzumab+Metformin in Operable and Locally Advanced HER2 Positive Breast Cancer
- Conditions
- HER-2 Positive Breast Cancer
- Interventions
- First Posted Date
- 2015-07-02
- Last Posted Date
- 2025-02-03
- Target Recruit Count
- 49
- Registration Number
- NCT02488564
- Locations
- 🇮🇹
Oncologia Medica AUSL Imola, Imola, Italy
🇮🇹U.O Oncologia AUSLdella Romagna, Rimini, RN, Italy
🇮🇹Day Hospital Oncologico, Ospedale Guastalla, Guastalla, Italy
Peptide Receptor Radionuclide Therapy With 90Y-Dotatoc in Relapsed/Refractory Diffuse Large B Cell and Mantle Cell Lymphomas
- First Posted Date
- 2015-07-02
- Last Posted Date
- 2018-03-19
- Target Recruit Count
- 1
- Registration Number
- NCT02488512
- Locations
- 🇮🇹
Nuclear Medicin Division, IRST IRCCS, Meldola, FC, Italy
PRednisone Plus EVerolimus in Patients With Metastatic Renal Cell Cancer After Failure of VEGFR -TKI
- First Posted Date
- 2015-06-24
- Last Posted Date
- 2018-01-16
- Target Recruit Count
- 8
- Registration Number
- NCT02479490
- Locations
- 🇮🇹
U.O Oncologia Medica, IRST IRCCS, Meldola, FC, Italy
🇮🇹Oncologia Medica, PO Rimini-Cattolica, AUSL della Romagna, Rimini, Italy
🇮🇹Oncologia Medica, PO Faenza, AUSL della Romagna, Faenza, RA, Italy
Temozolomide in Patients Affected by Relapsed Sensitive or Refractory Small Cell Lung Cancer With MGMT Methylation
- First Posted Date
- 2015-06-23
- Last Posted Date
- 2018-11-13
- Target Recruit Count
- 6
- Registration Number
- NCT02477813
- Locations
- 🇮🇹
Oncologia Medica, Azienda ospedaliera universitaria di Ferrara, Ferrara, FE, Italy
🇮🇹Oncologia Medica AOU Policlinico di Modena, Modena, MO, Italy
🇮🇹U.O. Oncologia Medica, Faenza, RA, Italy
A Phase II Study of Dose Density Regimen With Fluorouracil, Epirubicin and Cyclophosphamide at Days 1, 4 Every 14 Days With Filgrastim Support Followed by Weekly Paclitaxel in Women With Primary Breast Cancer.
- Conditions
- Women With Primary Breast Cancer
- Interventions
- Drug: FEC (Fluorouracil, Epirubicin, Cyclophosphamide) + filgrastim + paclitaxel
- First Posted Date
- 2014-08-26
- Last Posted Date
- 2014-08-26
- Target Recruit Count
- 11
- Registration Number
- NCT02225652
- Locations
- 🇮🇹
Irccs Irst, Meldola, FC, Italy
A Study of Lapatinib in Combination With Caelyx in Patients With Advanced HER2 Positive Pretreated Breast Cancer
- Conditions
- HER-2 Positive Breast CancerMalignant Neoplasm of Breast
- Interventions
- Drug: Lapatinib, Caelyx
- First Posted Date
- 2014-05-06
- Last Posted Date
- 2016-02-02
- Target Recruit Count
- 11
- Registration Number
- NCT02131506
- Locations
- 🇮🇹
UO Oncologia medica, IRCCS IRST, Meldola, FC, Italy
Phase II Study of Hypofractionated Radio-chemotherapy With Gemcitabine Plus Oxaliplatin for Unresectable Nonmetastatic Locally Advanced Pancreatic Cancer.
- Conditions
- Unresectable Pancreatic CancerNonmetastatic Pancreatic CancerLocally Advanced Pancreatic Cancer
- Interventions
- First Posted Date
- 2014-01-14
- Last Posted Date
- 2017-07-21
- Target Recruit Count
- 40
- Registration Number
- NCT02035072
- Locations
- 🇮🇹
Radiotherapy Unit, IRCCS IRST, Meldola, FC, Italy
A Phase II Study Evaluating the Role of Androgen Receptors as Targets for Therapy of Pre-treated Post-menopausal Patients With ER/PgR-negative/AR-positive or ER and/or PgRpositive/ AR-positive Metastatic Breast Cancer (ARTT)
- Conditions
- Metastatic BreastcancerEstrogen Receptor Negative NeoplasmEstrogen Receptor Positive Breast CancerProgesterone Receptor Positive TumorProgesterone Receptor Negative NeoplasmAndrogen Receptor Gene Overexpression
- Interventions
- First Posted Date
- 2013-12-04
- Last Posted Date
- 2016-09-29
- Target Recruit Count
- 20
- Registration Number
- NCT02000375
- Locations
- 🇮🇹
Oncologia medica PO Ravenna AUSL della Romagna, Ravenna, RA, Italy
🇮🇹Oncologia Medica PO Lugo, AUSL della Romagna, Lugo, RA, Italy
🇮🇹Oncologia medica , PO FAENZA, Ausl della Romagna, Faenza, RA, Italy
Phase II Study of Up-front Chemotherapy and Neo-adjuvant Short-course Radiotherapy for Resectable Rectal Carcinoma (COLORE)
- Conditions
- Rectal Carcinoma
- Interventions
- Drug: FOLFOX4Radiation: TomotherapyProcedure: TME (Total Mesorectal Excision)
- First Posted Date
- 2013-12-03
- Last Posted Date
- 2025-01-30
- Target Recruit Count
- 52
- Registration Number
- NCT02000050
- Locations
- 🇮🇹
UO Oncologia Medica IRCCS IRST, Meldola, FC, Italy
🇮🇹Oncologia Medica PO RAVENNA; FAENZA; LUGO, Ravenna, RA, Italy
The Role of Early Systematic Best Palliative Care Versus on Request Palliative Care Consultation During Standard Oncologic Treatment for Patients With Advanced Gastric or Pancreatic Cancers: a Randomized, Controlled, Multicenter Trial.
- Conditions
- Pancreatic NeoplasmGastric Neoplasm
- First Posted Date
- 2013-11-27
- Last Posted Date
- 2018-11-13
- Target Recruit Count
- 394
- Registration Number
- NCT01996540
- Locations
- 🇮🇹
U.O Oncologia medica, Lugo, RA, Italy
🇮🇹Palliative Care Clinic IRCCS IRST, Meldola, FC, Italy
🇮🇹S. Donato, Arezzo, Arezzo, Italy